openPR Logo
Press release

Epilepsy Device Market: for Epilepsy Devices Poised to Exceed $1 Billion by 2031 | Growing CAGR of 5.1%

03-18-2024 01:52 PM CET | Health & Medicine

Press release from: Allied Market Research (AMR)

/ PR Agency: Allied Market Research (AMR)
Epilepsy Device Market: for Epilepsy Devices Poised to Exceed $1

The global epilepsy devices market isx experiencing a remarkable surge, poised to exceed a valuation of $1.1 billion by 2031, as revealed by the latest market analysis. According to the report released by Allied Market Research, the market was valued at $675.23 million in 2021 and is projected to grow at a CAGR of 5.1% from 2022 to 2031.


๐‘๐ž๐ช๐ฎ๐ž๐ฌ๐ญ ๐…๐จ๐ซ ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐‚๐จ๐ฉ๐ฒ: https://www.alliedmarketresearch.com/request-sample/A14821


Epilepsy devices play a critical role in seizure detection and monitoring, offering hope and improved quality of life for millions affected by epilepsy worldwide. With advancements in technology, including deep brain stimulation (DBS), vagus nerve stimulation (VNS), and responsive neurostimulation (RNS), coupled with innovative wearable and conventional devices, the landscape of epilepsy management is rapidly evolving.

Epilepsy Devices Market Trends are rise in the geriatric population who are more susceptible to developing neurological diseases, a rise in the adoption of technologically advanced epilepsy devices, and an increase in awareness toward the benefits of using epilepsy devices in the effective diagnosis of seizures. For instance, according to National Health Service, epilepsy starts in people aged over 60 years. Furthermore, cryptogenic or stroke-related seizures are most common in elderly people.


๐Š๐ž๐ฒ ๐ˆ๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ ๐Ÿ๐ซ๐จ๐ฆ ๐ญ๐ก๐ž ๐‘๐ž๐ฉ๐จ๐ซ๐ญ:

โ—‰ ๐“๐ž๐œ๐ก๐ง๐จ๐ฅ๐จ๐ ๐ข๐œ๐š๐ฅ ๐€๐๐ฏ๐š๐ง๐œ๐ž๐ฆ๐ž๐ง๐ญ๐ฌ: The market showcases a diverse range of products, including conventional and wearable devices, EEG, Electrocardiography (EKG), Surface Electromyography (sEMG), Video Detection Systems, and more, catering to varied patient needs.

โ—‰ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐ƒ๐ฒ๐ง๐š๐ฆ๐ข๐œ๐ฌ: With a forecast period spanning from 2021 to 2031, the report provides a comprehensive analysis of market dynamics, identifying key drivers, restraints, and opportunities shaping the epilepsy devices market.

โ—‰ ๐†๐ฅ๐จ๐›๐š๐ฅ ๐Ž๐ฎ๐ญ๐ฅ๐จ๐จ๐ค: Major countries in each region are mapped based on their revenue contribution to the global market, providing valuable insights for stakeholders worldwide.

โ—‰ ๐‚๐จ๐ฆ๐ฉ๐ž๐ญ๐ข๐ญ๐ข๐ฏ๐ž ๐‹๐š๐ง๐๐ฌ๐œ๐š๐ฉ๐ž: Key market players such as Medpage Ltd, Abbott Laboratories, Empatica, Inc., Natus Medical Incorporated, and others are positioned strategically, enabling benchmarking and fostering a deeper understanding of market dynamics.


๐„๐ง๐ช๐ฎ๐ข๐ซ๐ž ๐๐ž๐Ÿ๐จ๐ซ๐ž ๐๐ฎ๐ฒ๐ข๐ง๐ : https://www.alliedmarketresearch.com/purchase-enquiry/A14821


๐‹๐ž๐š๐๐ข๐ง๐  ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐๐ฅ๐š๐ฒ๐ž๐ซ๐ฌ-

โ— Cadwell Industries

โ— Natus Medical Compumedics Limited

โ— Empatica Inc.

โ— LivaNova PLC

โ— Masimo Corporation

โ— Medpage Ltd.

โ— Medtronic plc

โ— Boston Scientific Corporation

โ— Abbott Laboratories


๐’๐ญ๐š๐ค๐ž๐ก๐จ๐ฅ๐๐ž๐ซ๐ฌ ๐’๐ญ๐š๐ง๐ ๐ญ๐จ ๐๐ž๐ง๐ž๐Ÿ๐ข๐ญ ๐Ÿ๐ซ๐จ๐ฆ:

โ—‰ Quantitative analysis of market segments and current trends

โ—‰ Insights into prevailing market opportunities

โ—‰ Porter's five forces analysis for profit-oriented business decisions

โ—‰ Identification of key growth strategies and application areas

With an emphasis on innovation and patient-centric care, the epilepsy devices market is poised for significant growth, revolutionizing epilepsy management globally.

๐ƒ๐ซ๐ข๐ฏ๐ž๐ซ๐ฌ, ๐‘๐ž๐ฌ๐ญ๐ซ๐š๐ข๐ง๐ญ๐ฌ, ๐š๐ง๐ ๐Ž๐ฉ๐ฉ๐จ๐ซ๐ญ๐ฎ๐ง๐ข๐ญ๐ข๐ž๐ฌ-

Rise in the prevalence of old age population that are more vulnerable to epilepsy and increase in awareness regarding the use of epilepsy devices drives the growth of the global epilepsy devices market. On the other hand, strict government regulations concerning the manufacturing of epilepsy device products and product approvals impede the growth to some extent. However, increase in focus on developing cost-effective epilepsy devices and surge in R&D investments in the discovery & development of advanced epilepsy devices are expected to create lucrative opportunities in the industry.

๐‚๐จ๐ง๐ญ๐š๐œ๐ญ ๐”๐ฌ:

David Correa

Portland, OR, United States

USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022,

UK: +44-845-528-1300

Hong Kong: +852-301-84916

India (Pune): +91-20-66346060

Fax: +1(855)550-5975

help@alliedmarketresearch.com

Web: https://www.alliedmarketresearch.com

๐€๐›๐จ๐ฎ๐ญ ๐”๐ฌ:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Epilepsy Device Market: for Epilepsy Devices Poised to Exceed $1 Billion by 2031 | Growing CAGR of 5.1% here

News-ID: 3434530 • Views: โ€ฆ

More Releases from Allied Market Research (AMR)

Online Music Streaming Market Demand will reach a value of US$ 24,711.3 million by 2027 at a CAGR of 12.34%
Online Music Streaming Market Demand will reach a value of US$ 24,711.3 million โ€ฆ
The global online music streaming market size is expected to reach $24,711.3 million by 2027 at a CAGR of 12.34% from 2021 to 2027. Request The Sample PDF Of This Report: https://www.alliedmarketresearch.com/request-sample/11521 Online music streaming is a means of delivering music without downloading any file from the internet. Music is stored on the servers' database and is instantly transferred to the streamer or users' device in realโ€ฆ
Low-E Glass Market Growth Trends: Global Analysis of Leading Players and Business Development Forecast to 2032
Low-E Glass Market Growth Trends: Global Analysis of Leading Players and Busines โ€ฆ
According to the study, the global low-e glass market was valued at $11.9 billion in 2022 and is projected to reach $21.0 billion by 2032, growing at a CAGR of 5.9% from 2023 to 2032. Download Sample Pages of Research Overview: https://www.alliedmarketresearch.com/request-sample/A15849 Market Drivers and Challenges: - The growing emphasis on energy efficiency and cost reduction is propelling the demand for low-emissivity (Low-E) glass globally. Despite higher upfront costs compared to traditional glass,โ€ฆ
Sunflower Lecithin Market: Industry Development Challenges, Opportunities & Key Manufacturers Analysis to 2032
Sunflower Lecithin Market: Industry Development Challenges, Opportunities & Key โ€ฆ
According to the report, the global sunflower lecithin market was valued at $324.6 million in 2018 and is projected to reach $754.8 million by 2032, growing at a CAGR of 5.7% from 2023 to 2032. Download Sample Pages of Research Overview: https://www.alliedmarketresearch.com/request-sample/A156654 What is Sunflower Lecithin? Sunflower lecithin is a natural lipid blend derived from sunflower seeds, either mechanically or chemically, and is prized for its superior emulsifying and stabilizing properties. Composed primarilyโ€ฆ
Bio-Renewable Chemicals Companies Analysis and Developments by 2031
Bio-Renewable Chemicals Companies Analysis and Developments by 2031
According to the report, the global bio-renewable chemicals market was valued at $2.5 billion in 2021 and is projected to reach $7.4 billion by 2031, registering a CAGR of 11.6% from 2022 to 2031. The study provides an in-depth analysis of market dynamics, emerging trends, key investment areas, value chains, regional insights, and competitive landscapes. Download Sample Pages of Research Overview: https://www.alliedmarketresearch.com/request-sample/156 Market Drivers, Restraints, and Opportunities Drivers: - Technological advancements and innovations inโ€ฆ

All 5 Releases


More Releases for Epilepsy

Portable Epilepsy Monitoring Market in 2025
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Portable Epilepsy Monitoring Market- (By Product Type (Device Type (Chest Sensor, Watch Sensor, Monitors, Cameras, Mattresses and Pillows, and Others) and Service), By End User (Hospitals, Ambulatory Surgery Centres & Clinics, Neurology Centres, and Home Care Settings)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031." According to the latest research by InsightAce Analytic, the Globalโ€ฆ
Top 10 Epilepsy Companies Analysis (2024)
Epilepsy also known as seizure disorder, is a chronic noncommunicable disease that affects brain. Epilepsy affects people of all races, ethnic backgrounds, genders, and ages. Get More Details with Sample PDF Copy @ https://www.theinsightpartners.com/sample/TIPRE00016405/?utm_source=OpenPR&utm_medium=10129 Major Companies operating in the Epilepsy Market are: โ€ข Idexx Laboratories Inc. โ€ข PBD Biotech Ltd โ€ข Thermo Fisher Scientific Inc. โ€ข Innovative Diagnostics SAS โ€ข Neogen Corp โ€ข Enfer Labs โ€ข bioMerieux SA โ€ข Ring Biotechnology Co Ltd โ€ข Bionote Inc. โ€ข Shenzhen Bioeasy Biotechnology Co Ltd. Contact Us: If you have any queries about this report or ifโ€ฆ
Epilepsy Market: Trends, Opportunities, and Challenges
Epilepsy is a neurological disorder characterized by recurrent seizures, which are caused by abnormal electrical activity in the brain. This condition affects millions of people globally, making it one of the most common neurological disorders. As the global burden of epilepsy increases, the demand for effective treatments and solutions continues to grow. The epilepsy market is evolving rapidly, with advancements in medication, diagnostics, and therapeutic technologies. This guest post aimsโ€ฆ
Epilepsy with Myoclonic - Atonic Seizures Therapeutics Market - Breaking the Sei โ€ฆ
Newark, New Castle, USA: The "Epilepsy with Myoclonic-Atonic Seizures Therapeutics Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Epilepsy with Myoclonic - Atonic Seizures Therapeutics Market: https://www.growthplusreports.com/report/epilepsy-with-myoclonic-atonic-seizures-therapeutics-market/8029 Thisโ€ฆ
Rising Instances of Pediatric Epilepsy to Pave Novel Growth Avenues in Epilepsy โ€ฆ
Owing to large scale prevalence of epilepsy cases, inclusive of pediatric epilepsy, the market for epilepsy drugs is likely to remain agile in the coming years. Prevalent amongst both male and female demographics alike, epilepsy is a critical condition that affects the brain both partially as well as in whole. Lucrative reimbursement policies, coupled with growing patient awareness about novel therapeutics are likely to reflect favorably on the growth curveโ€ฆ
Epilepsy Drugs Market 2017- UCB, EISAI, Pfizer
Epilepsy Drugs Market is likely to reach nearly USD 5.5 Billion by the year end of 2021. Market growth can be attributed to factors such as rising incidence of neurological disorders, growing disease awareness, introduction of novel antiepileptic drugs (AEDs), strong government support and initiatives. Moreover, increasing R&D investment and launch of extended-release formulations are further expected to fuel the market growth. However, high cost of patented drugs, concerns over decreasingโ€ฆ